Laird Norton Wetherby Wealth Management’s Vertex Pharmaceuticals VRTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $2.53M | Buy |
|
|||||
|
2024
Q4 | $2.25M | Sell |
|
|||||
|
2024
Q3 | $2.73M | Sell |
|
|||||
|
2024
Q2 | $2.79M | Buy |
|
|||||
|
2024
Q1 | $2.48M | Sell |
|
|||||
|
2023
Q4 | $2.42M | Buy |
|
|||||
|
2023
Q3 | $2.06M | Buy |
|
|||||
|
2023
Q2 | $2.05M | Sell |
|
|||||
|
2023
Q1 | $1.89M | Buy |
|
|||||
|
2022
Q4 | $1.67M | Buy |
|
|||||
|
2022
Q3 | $1.66M | Buy |
|
|||||
|
2022
Q2 | $1.47M | Sell |
|
|||||
|
2022
Q1 | $1.48M | Buy |
|
|||||
|
2021
Q4 | $1.15M | Buy |
|
|||||
|
2021
Q3 | $740K | Sell |
|
|||||
|
2021
Q2 | $889K | Sell |
|
|||||
|
2021
Q1 | $1.03M | Sell |
|
|||||
|
2020
Q4 | $1.2M | Sell |
|
|||||
|
2020
Q3 | $1.52M | Sell |
|
|||||
|
2020
Q2 | $1.66M | Buy |
|
|||||
|
2020
Q1 | $1.35M | Buy |
|
|||||
|
2019
Q4 | $1.14M | Buy |
|
|||||
|
2019
Q3 | $852K | Buy |
|
|||||
|
2019
Q2 | $874K | Buy |
|
|||||
|
2019
Q1 | $862K | Buy |
|
|||||
|
2018
Q4 | $754K | Buy |
|
|||||
|
2018
Q3 | $820K | Buy |
|
|||||
|
2018
Q2 | $684K | Sell |
|
|||||
|
2018
Q1 | $665K | Buy |
|
|||||
|
2017
Q4 | $555K | Buy |
|
|||||
|
2017
Q3 | $554K | Buy |
|
|||||
|
2017
Q2 | $435K | Buy |
|
|||||
|
2017
Q1 | $348K | Buy |
|
|||||
|
2016
Q4 | – | Sell |
|
|||||
|
2016
Q3 | $271K | Buy |
|
|||||
|
2016
Q2 | $210K | Sell |
|
|||||
|
2016
Q1 | $256K | Sell |
|
|||||
|
2015
Q4 | $443K | Sell |
|
|||||
|
2015
Q3 | $378K | Buy |
|
|||||
|
2015
Q2 | $352K | Buy |
|
|||||
|
2015
Q1 | $297K | Buy |
|
|||||
|
2014
Q4 | $282K | Buy |
|
|||||
|
2014
Q3 | $225K | Buy |
|